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Objective: To investigate whether endothelial mono-
layer permeability changes induced by inflammatory
mediators  are  affected  by  the  extracellular  matrix
protein used for cell seeding.
Methods: Human umbilical venular endothelial cells
(HUVEC)  were  grown  to  confluent  monolayers  on
membranes coated with either collagen, fibronectin
or gelatin. The permeability to albumin and dextran
was then assessed, both under normal conditions and
after  treatment  with  tumor  necrosis  factor-alpha
(TNF-a ) and bacterial lipopolysaccharide (LPS).
Results: With any of the three protein coatings, tight
junctions were formed all over the monolayers. The
permeability  of  the  coated  membranes  to  albumin
and  dextran  was  reduced  strongly  by  confluent
monolayers; the relative reduction was similar for the
three  matrix  proteins  used.  Pre-incubation  of  the
monolayers  with  either  TNF-a or  LPS  increased
permeability dose dependently. However, the relative
increase due to either treatment was independent of
the protein used for membrane coating.
Conclusion: The extracellular matrix protein used for
initial seeding of endothelial cultures plays a minor
role in determining the permeability changes induced
in HUVEC monolayers by inflammatory mediators.
Key  words:  Endothelium,  Extracellular  matrix  (ECM),
HUVEC,  Inflammatory  mediator,  Tumor  necrosis  factor,
endotoxin, monolayer permeability
Introduction
The vascular endothelium acts as a dynamic barrier
that selectively  restricts the  passage  of  plasma  and
cells from the blood into the adjacent tissues. Local
and reversible alterations of barrier function typically
occur as part of the immune response during which
inflammatory mediators cause a transient increase of
vascular  permeability  resulting  in  the  formation  of
tissue oedema. However, during systemic inflamma-
tory response syndrome (SIRS),1 over-production of
inflammatory  mediators  may  irreversibly  damage
vascular  integrity  and  cause  excessive  loss  of  fluid
from the circulation. This hazardous event may lead to
prolonged  tissue  hypoperfusion,  organ  dysfunction
and death.2 Therefore, prevention of vascular damage
could  contribute  to  improved  survival  of  patients
suffering from SIRS.3,4 Many have studied the role of
the  endothelium  in  vascular  permeability  using  in
vitro models of endothelial monolayers cultured on
semi-permeable  supports.5–7 Multiple  mechanisms
may be involved in increased endothelial permeabil-
ity, such as cell contraction and retraction,8 enhanced
transcellular  vesicle  transport,9 disruption  of  inter-
cellular junctions10 and apoptosis.11
Recently,  it  has  been  suggested  that  endothelial
permeability  may  also  depend on  the  composition
and structure of the underlying extracellular matrix
(ECM).12 For  example,  it  has  been  shown  that
fibronectin  significantly  contributes  to  endothelial
monolayer permeability by providing attachment sites
for  ECM  proteins  and  endothelial  cells.13 When
monolayers cultured on fibronectin were treated with
tumor  necrosis  factor-a (TNF-a),  a  permeability
increase was observed which was accompanied by a
loss of fibronectin from the ECM.14 TNF-a also affects
the expression of other matrix receptors on endothe-
lial  cells,  confirming  a  role  for  endothelial  –  ECM
contacts  in  vascular  permeability.15 Furthermore,
stimulation of endothelial cells  with TNF-a induced
the  expression  of  a  96-kDa  matrix  metalloprotei-
nase,16 suggesting  that  matrix  degradation may  be
involved in increased permeability.17
For the purpose of studying endothelial permeabil-
ity  in  vitro,  these  findings  seem  to  imply  that
endothelial cells should be cultured on (a mixture of)
ECM proteins, preferably containing fibronectin, but
other ECM coatings like gelatin and different types of
collagen  are  used  frequently.18 It  remains  unclear
whether different coatings eventually result in differ-
ent monolayer permeability changes under the influ-
ence of inflammatory mediators. A comparison of in
vitro studies on endothelial permeability is hampered
by the many differences in the origin and species of
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ences in the design of the monolayer system, includ-
ing the matrix used for cell seeding.
Therefore,  we  have  compared  the  permeability
characteristics of human umbilical  venular endothe-
lial  cells  (HUVEC)  seeded  on  membranes  coated
with either collagen, fibronectin or gelatin. For this
purpose, we have selected a suitable in vitro model
that supports the attachment and growth of HUVEC,
and  allows  restricted  diffusion  of  macromolecules,
visual examination by  both bright  field microscopy
and  ultramicroscopy,  and  easy  and  simultaneous
permeability  determinations.  The  inflammatory
mediators  TNF-a and  bacterial  lipopolysaccharide
(LPS), which are involved in the onset of SIRS, have
been  shown  to  enhance  endothelial  permeability
both  in  vivo and  in  vitro.19–22 We  measured  the
permeability for both albumin and dextran in untrea-
ted  HUVEC  monolayers  and  in  cultures  after  treat-
ment with either TNF-a or LPS.
Materials and methods
Materials
Culture medium M199, supplemented with 25mmol/l
HEPES, Earl’s salts and L-glutamine, as well as heat-
inactivated  newborn  calf  serum  (NCS),  penicillin-
streptomycin and trypsin/EDTA were obtained from
Life Technologies (Paisley, Scotland). Normal human
serum was supplied by a local transfusion service. A
pool of serum of at least five donors was first heat
inactivated  (30min  at  56°C),  and  stored  at  –20°C
before use. Transwell-well culture inserts, tissue cul-
ture  plates  and  flasks  were  all  from  Costar  (Cam-
bridge, MA). Fluorescin-labelled bovine serum albu-
min  (FITC-BSA),  rhodamin-labelled  dextran
(RITC-DEX,  mean  molecular  weight  70,000),  col-
lagenase type I (from Clostridium hystolyticum), pig
skin gelatin (type A) and LPS (E. coli, strain 055:B5)
were purchased from Sigma Chemical (St Louis, MO).
Human  fibronectin  was  obtained  from  Boehringer
Mannheim (Mannheim, Germany). A crude fraction of
endothelial  cell  growth  factors  (ECGF)  was  kindly
provided by the Department of Pediatrics, University
Hospital of Nijmegen, The Netherlands. Heparin was
obtained from Leo pharmaceutical products (Weesp,
The  Netherlands). Recombinant human TNF-a (6 ´
107 U/mg,  endotoxin  content  <  1EU/mg)  was
obtained from Bender & Co, Vienna.
Isolation and culture of HUVEC
Endothelial cells were isolated according to a mod-
ification  of  the  method described by  Jaffe  and  co-
workers.23 Upon delivery the umbilical  cords were
placed  in  sterile,  ice  cold  cord buffer  (140mmol/l
NaCl, 4mmol/l KCl, 11mmol/l D-glucose, 10mmol/l
HEPES,  100IU  penicillin,  and  0,1mg/ml  streptomy-
cin, pH 7,3) and stored at 4°C until use. In brief, the
umbilical vein was rinsed with cord buffer to remove
blood and debris from the lumen after which the vein
was filled with medium M199 containing 0.1% (w/v)
collagenase. Endothelial cells were detached by incu-
bation for 20min at 37°C and harvested by collecting
the collagenase solution. After centrifugation (5min at
300 ´ g),  the  cells  were  resuspended in  complete
medium (M199 with 10% NCS, 10% normal human
serum,  50U/ml  penicillin,  50mg/ml  streptomycin,
150mg/ml  crude  ECGF  and  5U/ml  heparin)  and
seeded onto 0.1% gelatin-coated 25cm2 culture flasks.
The cultures were kept in a humidified incubator at
37°C under a 5% CO2/95% air atmosphere. After one
day, and then three times weekly, the culture medium
was refreshed. Confluent cultures (typically yielding
105 cells/cm2 or more) were passaged by detaching
the cells with 0.5mg/ml trypsin and 0.2mg/ml EDTA,
which was followed by centrifugation and resuspen-
sion in complete medium. For appropriate growth, a
split  ratio  of  1:2  or  1:3  was used. All  experiments
were performed on cells that had been passaged less
than four times.
Endothelial origin of the cultures was confirmed by
phase contrast microscopy, which revealed confluent
cultures displaying a typical cobblestone morphology,
while immunocytochemical analysis revealed positive
staining for von Willebrand Factor and CD31 (platelet
endothelial cell adhesion molecule (PECAM)-1). Activa-
tion with TNF-a or LPS-induced expression of inter-
cellular  adhesion  molecule  (ICAM)-1  and  E-selectin
(data not shown).
Preparation of microporous membranes and
cell seeding
For permeability determinations, two different culture
inserts  were used, one  containing  a  polyester  (PE)
membrane (Transwell Clear) and the other containing
a  collagen  pre-treated  polyethylene  terephtalate
(PTFE)  membrane  (Transwell  COL).  Both  types  of
membrane  contained 0.4mm  diameter pores  and  a
growth area of 1cm2. However, differences existed in
pore density and membrane thickness. While the PTFE
membranes were obtained with a collagen (bovine,
type I/III) coating in place, and thus were ready for
culturing, the PE membranes were prepared for cell
seeding by overnight incubation at room temperature
with  either  fibronectin  (10mg/cm2),  or  gelatin
(10mg/cm2) in medium M199. No significant differ-
ence in permeability was observed between uncoated
and coated PE membranes (data not shown).
The inserts were placed in 12-well culture plates,
resulting in a two-compartment system separated by
the membrane. Approximately 105 cells/cm2 in 0.5ml
of complete medium were seeded at the upper side of
the membrane, whereas 1.5ml of complete medium
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prevented  hydrostatic  fluid  pressures  across  the
membranes.  Both  compartments  were  frequently
replenished  with  complete  medium  as  described.
Cultures  were  grown  for  six  days,  resulting  in  the
formation of confluent monolayers, which was con-
firmed by phase contrast light microscopy.
In  one  experiment,  the  confluent  cell  layer  was
selectively removed from  the membranes. This was
achieved by briefly incubating the monolayers with a
25mmol/l  NH4OH  solution.  Removal  of  attaching
cells from the membrane was confirmed by transmis-
sion electron microscopy examination.
Transmission electron microscopy of HUVEC
monolayers
Cultured cells on Transwell inserts were washed twice
with  serum-free  medium  prior  to  fixation  with  2%
glutaraldehyde  in  phosphate-buffered  saline  (PBS).
After 60min of fixation the Transwells were washed
with PBS and treated with 1% OsO4 for 30min and
washed again with PBS. After several steps of dehydra-
tion, with 30%–70%–90%–100% alcohol, followed by
1:1 mix, 1:2 mix and pure epon 812, the membranes
were  dissected  from  the  Transwells  with  a  small
diamond knife and flat embedded in pure epon 812.
Ultrathin  sections were stained with  uranyl  acetate
and lead nitrate. The sections were examined with a
JEOL 1200EX/II electron microscope (Tokyo, Japan)
at 60kV.
TNF-a and LPS treatment
Dilutions of TNF-a (50,  500pg/ml and 10ng/ml) or
LPS (50,500ng/ml  and 10mg/ml)  were prepared in
complete medium. In the LPS experiments, medium
containing  20%  normal  human  serum  was  used
instead of heat-inactivated human and calf sera. At the
start  of  the  experiment  0.5ml  of  TNF-a-  or  LPS-
containing medium was added to the upper compart-
ment of the chamber. After overnight incubation at
37°C,  the  permeability  of  the  monolayers  was
determined.
Permeability studies
For the detection of macromolecular passage across
the  membranes,  a  tracer  solution  containing  both
FITC-labelled BSA (250mg/ml) and RITC-labelled dex-
tran (250mg/ml) was prepared in complete medium.
In  the  upper  compartment,  culture  medium  was
replaced by 0.5ml of the tracer solution, while the
lower  volume  was  refreshed  with  1.5ml  complete
medium.  After  1,  6  and  24h  of  diffusion,  250ml
samples were drawn from  the lower compartment,
which was replenished with an equal volume fresh
medium  each  time.  The  collected  samples  were
diluted with 1ml PBS and the concentrations of FITC-
BSA and  RITC-DEX  were  measured  using  a  Hitachi
5000  fluorophotospectrometer,  at  emission/excita-
tion  wavelengths  of  495/520nm  and  560/580nm,
respectively. The albumin and dextran concentrations
in the samples were calculated using linear regression
of a diluted series of the tracer.
Statistical analysis
Differences  between  permeability  to  albumin  and
dextran were calculated by paired Student t-test. In
order to  control  for  the  different  membrane  types
used  in  our  studies,  the  permeability  of  untreated
HUVEC monolayers was calculated as a ratio of the
corresponding  unseeded  membranes.  Similarly,  the
effect of treatment of monolayers on different mem-
branes was compared to control monolayers cultured
on corresponding membranes. Differences between
permeability  ratios  were  calculated  by  Kruskall–
Wallis non-parametric ANOVA.
Results
Permeability of membranes with different
protein coatings and without seeded cells
Membranes  coated  with  collagen,  fibronectin  or
gelatin  showed  significantly  different  permeability
rates.  The  diffusion  of  both  albumin  and  dextran
occurred  faster  across  the  collagen-coated  mem-
branes than across the fibronectin or gelatin-coated
membranes  (Fig.  1).  Permeability  to  albumin  and
dextran  appeared  to  be  essentially  the  same,
although  average  dextran  concentrations  in  the
lower  compartment  were  almost  invariably  slightly
less  than  albumin  concentrations. However,  during
the permeability assay this difference never reached
statistical significance.
After 1h of diffusion, the concentrations of albu-
min  and dextran  in  the lower compartment of  the
collagen-coated  membrane  inserts  were  11.2  ±
4.5mg/ml  and  10.1  ±  4.4mg/ml,  respectively. This
accounted for approximately 17%  of  the calculated
equilibrium concentration of 62.5mg/ml. Significantly
less albumin and dextran accumulated in the lower
compartment  of  the  gelatin-  or  fibronectin-coated
membranes, both allowing less than 2mg/ml during
the first hour, or about 5% of the calculated equilib-
rium concentration. At the end of the assay, after 24h,
these differences were still significant, although less
explicit: the tracer concentration in the lower com-
partment  of  the  collagen-coated  membrane  inserts
were  49.4  ±  4.3mg/ml  (for  albumin)  and  46.4  ±
4.9mg/ml (for dextran), while less than 34mg/ml of
either molecule had accumulated in the lower com-
partment of  the fibronectin  or gelatin-coated mem-
brane inserts.
Endothelial permeability on different matrices
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Culturing  of  HUVEC  for  six  days  resulted  in  the
growth  of  confluent  monolayers  that  had  formed
tight junctions throughout the culture. As shown in
Fig.  2,  these junctions were present between cells
grown on all three different matrix proteins. On all
membranes  the  permeability  to  albumin  and  dex-
tran  was  significantly  restricted  by  HUVEC  mono-
layers  (Fig.  3).  Although  monolayers  cultured  on
collagen-coated  PTFE  membranes  allowed  more
albumin  and dextran passage than monolayers cul-
tured  on  gelatin-or  fibronectin-coated  PE  mem-
branes,  comparing  the  permeability  to  the  corre-
sponding  unseeded  membranes  showed  that  the
relative  restriction  to  albumin  and  dextran  by
HUVEC monolayers was similar  for the three coat-
ings. For instance, after 1h, monolayers cultured on
collagen, fibronectin  or gelatin  reduced passage  of
albumin by 87.0 ± 4.8% (n = 12), 79.8 ± 5.6% (n =
4)  or  82.2  ±  4.7%  (n =  4),  respectively,  when
compared  to  the  permeability  of  unseeded  mem-
branes. After  24h,  these  percentages  were  55.5  ±
7.2, 61.7 ± 1.9 and 59.3 ± 8.2, respectively. Similar
data could be calculated for the dextran permeabil-
ity, but the relative restriction was not significantly
different between the three coatings.
In  order to  investigate  whether  the  extracellular
matrix, produced by the cells during culture, differ-
ently  contributed  to  the  permeability  after  initial
seeding on either protein, HUVEC were grown for six
days and the permeability was measured. Thereafter,
the cells were lysed, leaving membranes with matrix
(coating plus the extracellular matrix laid down by
the  cells)  only  and  the permeability  was measured
again. After cell lysis, albumin permeability measured
after 1h of diffusion was increased by a factor 4.4 ±
0.8 (n = 4) on collagen-coated membranes, 4.9 ± 0.1
on fibronectin-coated membranes and 4.5 ± 0.1 on
gelatin-coated  membranes.  Dextran  permeability
changed accordingly, but as with albumin, the perme-
ability  increase  after  cell  lysis  did  not  significantly
differ between the collagen-, gelatin- and fibronectin-
coated membranes.
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FIG.  1.  Permeability of  Transwell  culture  inserts  for  FITC-
albumin  and  RITC-dextran.  Bars  represent  the  abluminal
concentration in mg/ml of permeated albumin (hatched bars)
and dextran (filled bars) after 1 (left panel), 6 (middle panel)
and 24 (right panel)h of equilibration. Data represent at least
four  independent measurements  originating  from  two  or
more experiments and are expressed as mean ± SD. Culture
inserts: COL = collagen coated, FN = fibronectin coated, GEL
= gelatin coated.
FIG.  2.  Ultramorphologic  characteristics  of  HUVEC  mono-
layers cultured on different matrices. HUVEC cultured on (A)
collagen- (B) fibronectin- and (C) gelatin-coated membranes.
Note junctional complexes between adjacent cells  (arrow-
heads). Magnification 30,000´ .Permeability of TNF-a or LPS-pretreated
HUVEC monolayers
Pre-incubation  of  the  monolayers  with  increasing
doses of TNF-a or LPS resulted in a dose-dependent
increase in monolayer permeability. In order to allow
a quantitative comparison of the effects induced by
these  inflammatory  mediators  on  the  monolayers
grown  on  the  different  coatings,  permeability  was
expressed as the ratio between treated and untreated
monolayers. While a dose of 50pg/ml of TNF-a was
insufficient to enhance the permeability for albumin,
a  dose of  500pg/ml  of TNF-a induced  a  moderate
permeability increase of the monolayers cultured on
collagen,  fibronectin  or  gelatin  (Fig.  4A). A  further
stimulation was observed at a concentration of 10ng/
ml TNF-a. After 1h of diffusion, the relative increase
ranged from 2.0 ± 0.4 (on gelatin) to 2.3 ± 0.2 (on
collagen). The TNF-a effect could be observed on all
the  coatings  and  no  significant  differences  were
observed  between  monolayers  cultured  on  either
collagen, gelatin or fibronectin. After 6  and 24h of
diffusion, the permeability difference between TNF-a
treated monolayers and control monolayers gradually
declined, resulting in a ratio close to 1. Still,  at the
highest dose the effect seemed persistent for at least
24h: at this time the ratio between treated and non-
treated  monolayers  ranged  between  1.2  ±  0.2  (on
collagen) to 1.3 ± 0.04 (on gelatin). A similar picture
emerged for the permeability to dextran (Fig. 4B).
Pre-incubation  with  bacterial  LPS  also  induced  a
dose-dependent increase in permeability which, like in
the  TNF-a experiments,  seemed  qualitatively  and
quantitatively independent of the protein on which
the monolayers were initially cultured. However, the
enhanced permeability  seemed less persistent after
LPS pre-incubation than after pre-incubation with TNF-
a. After 1h of diffusion, 500ng/ml LPS had induced an
albumin permeability which was a factor 1.2 ± 0.2 (on
fibronectin) to 1.5 ± 0.3 (on collagen) higher than the
permeability  in  untreated  monolayers  (Fig.  5A). At
10mg/ml LPS a further increase was observed ranging
from a factor 1.9 ± 0.7 (on gelatin) to 2.3 ± 0.2 (on
collagen). Similar values were obtained from dextran
measurements  (Fig.  5B).  However,  during  further
incubation  of  albumin  and  dextran  on  LPS-treated
monolayers a rapid decline towards control monolayer
permeability was observed, reaching a ratio after 6 and
24h that was not significantly different from 1.
Discussion
We have investigated the influence of different, but
commonly  used,  matrix  protein  substrates  on  the
permeability  of  resting,  and  TNF-a-  or  LPS-treated
HUVEC  monolayers  and  found  no  essential  differ-
ences between cells seeded on collagen, fibronectin
or gelatin.
Endothelial permeability on different matrices
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FIG.  3.  Permeability  of  HUVEC  monolayers  cultured  on
collagen, fibronectin and gelatin. Bars represent the ablumi-
nal concentration in mg/ml of permeated albumin (hatched
bars) and dextran (filled bars) in time (cf. legend to Fig. 1).
Data  represent  at  least  four  independent  measurements
originating  from  two  or  more  experiments  and  are
expressed as mean ± SD.
FIG. 4. Permeability of  TNF-a-treated  HUVEC  monolayers.
The  increase  in  permeability  to  albumin  (panel  A)  and
dextran (panel B) is expressed as the permeability ratio (±
SD,  n = 4) between treated and untreated monolayers. In
panels, from  left to right, the permeability ratio of  mono-
layers  cultured  on  collagen  (COL),  fibronectin  (FN)  and
gelatin (GEL), after 1, 6 and 24h of diffusion is shown. Open
bars: 50pg/ml TNF-a; grey bars: 500pg/ml TNF-a; black bars:
10ng/ml TNF-a.One  could  think  of  several  reasons  for  such  a
difference  to  exist. The  attachment  and  growth  of
endothelial cells in vitro depends at least in part on
specific binding sites provided by the ECM. Also, the
ECM is involved in mechanisms by which inflamma-
tory mediators cause increased endothelial permea-
bility and loss of monolayer integrity. These receptor-
mediated  mechanisms  include:  disruption  of
cell–cell  contacts by  cytoskeletal and/or  junctional
reorganization and alteration of endothelial adhesion
molecule  expression,24 disruption  of  cell–matrix
contacts  by  altering  endothelial  matrix  receptor
expression and loss of cell attachments sites in the
ECM;25 disruption  of  matrix–matrix  contacts  by
proteolytic  degradation  and  remodelling  of  the
ECM.16 Despite  the  apparent  contribution  of  ECM
proteins on endothelial permeability, different  ECM
proteins, as well as mixtures of ECM proteins, have
been used for  endothelial cell culturing.
For the evaluation of endothelial monolayer perme-
ability,  multi-well  culture  inserts suited with micro-
porous membranes were used in this study. A major
advantage of these culture inserts is that they allow an
easy and multiple analysis of monolayer permeability,
with only minor modifications of the standard culture
conditions. Moreover, these inserts all allowed visual
examination of  the  monolayer before and  after the
permeability assay. Across unseeded membranes, the
accumulation  of  albumin  appeared  always  slightly
faster than that of dextran. Physical properties, like
shape, diameter and charge, of these molecules could
be responsible for this difference. Untreated cultured
HUVEC monolayers, and TNF-a- or LPS-treated mono-
layers, did not show a clear preference for the passage
of either albumin or dextran. Since albumin passage
occurs  by  both  active  vesicular  and  paracellular
transport,  while  dextran  only  passively  diffuses
through the intercellular clefts,9,26 we conclude that
in  our  experiments  diffusion  via  the  transcellular
route contributes less to the permeability of resting
and  activated monolayers  and  that  the  majority  of
albumin and dextran pass the endothelial monolayer
by means of the paracellular route.
HUVEC  monolayers  cultured  on  collagen-,  fibro-
nectin- or gelatin-coated membranes did not display
different  morphologic  characteristics,  as  was
revealed by  light  and  transmission electron micros-
copy. All  monolayers  displayed  typical  cobblestone
morphology  and  tight  junctions  were  abundantly
present  between  neighbouring  cells.  Confluence
was usually achieved within six days and was inde-
pendent of the type of coating used. In the permea-
bility experiments all differences observed between
the monolayers cultured on the three proteins could
be attributed to the original differences observed in
the unseeded filters. Thus, collagen, fibronectin and
gelatin are all suitable  as a substrate for the attach-
ment and growth of endothelial cells in vitro, and in
our model, these substrates do not induce different
responses  to  inflammatory  mediators.  We  assume
that  additional  ECM  proteins,  produced  by  the
endothelial  cells  and  laid  down  into  the  ECM,
mediate  most  of  the  endothelial–ECM  interactions
involved in monolayer permeability. The production
of ECM proteins, including fibronectin, laminin and
type  IV  collagen,  by  endothelial  cells  in  vitro has
been  previously  shown by  others.27 In our  experi-
ments we did not see a difference in the membrane
permeability changes induced by a procedure which
removed  the  cells  while  leaving  the  ECM  on  the
membrane.  Although  the  eventual  composition  of
the ECM may differ between monolayers cultured on
collagen, fibronectin and gelatin, its contribution to
the  permeability  of  untreated  and  TNF-a or  LPS-
HUVEC  monolayers  apparently  is  of  minor  signifi-
cance. When the monolayers were exposed to TNF-
a,  a  dose-dependent  increase  of  permeability  was
observed,  which  is  in  accordance  with  previous
observations.20 Although loss of fibronectin has been
associated with a TNF-a-mediated increase of perme-
ability,12 we  did  not  observe a  difference  between
monolayers  cultured  on  collagen-,  fibronectin-  or
gelatin-coated  membranes.  Possibly,  in  our  experi-
ments  TNF-a treatment  did  not  induce  significant
matrix  degradation  or  matrix  degradation  equally
affected the three ECM proteins investigated.
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FIG. 5. Permeability of LPS-treated HUVEC monolayers. The
increase in permeability to albumin (panel A) and dextran
(panel B) is expressed as the permeability ratio (± SD, n = 4)
between treated and untreated monolayers. In panels, from
left to right, the permeability ratio of monolayers cultured on
collagen (COL), fibronectin (FN) and gelatin (GEL), after 1, 6
and 24h of diffusion is shown. Open bars: 50ng/ml LPS; grey
bars: 500ng/ml LPS; black bars: 10mg/ml LPS.When compared to TNF-a, LPS pre-treatment resul-
ted  in  a  moderate  and  more  transient  increase  of
permeability, suggesting that continuous exposure of
LPS  may  be  required  for  a  prolonged  permeability
enhancement. Others have shown that the effect of
LPS  on  endothelial  permeability  depends  on  the
availability  of  soluble  CD14  and  lipopolysaccharide
binding  protein  in  serum.28 Further  studies  are
needed to reveal eventual differences between TNF-a-
and  LPS-induced  endothelial  permeability  and  the
reversibility of these changes.
In conclusion, we have demonstrated that cultured
HUVEC  monolayers seeded on various  proteins are
equally suitable as a model for vascular permeability,
showing physiologically relevant responses to inflam-
matory stimuli. Apparently, the initial differences in
cellular environment are unimportant with respect to
the eventual permeability characteristics of the con-
fluent  monolayer,  possibly  as  a  result  of  additional
ECM laid down during culture.
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